News Author: Roxanne Nelson Publish date: September 24, 2015
Key clinical point: Neutrophil lymphocyte ratio (NLR) can be correlated with poor disease-specific survival in stage IV breast cancer and the chan...
News Author: Roxanne Nelson Publish date: September 21, 2015
Key clinical point: Intermittent androgen deprivation is not inferior to continuous therapy in regards to overall survival.
News Author: Roxanne Nelson Publish date: September 18, 2015
Key clinical point: Reovirus, a naturally occurring oncolytic virus, in combination with anti-CD20 immunotherapy, may have benefit for the treatme...
News Author: Roxanne Nelson Publish date: September 17, 2015
Key clinical point:Mutation testing may aid treatment selection in patients with chronic myeloid leukemia (CML) when selecting an alternative ther...
News Author: Roxanne Nelson Publish date: September 9, 2015
Whole-exome sequencing of the patients with myeloma identified 15 significantly mutated genes. With the exception of NRAS and KRAS, the other genes ar...
News Author: Roxanne Nelson Publish date: September 9, 2015
Key clinical point: Adjuvant granulocyte macrophage colony-stimulating factor and peptide vaccination did not significantly improve relapse-free o...
News Author: Roxanne Nelson Publish date: September 8, 2015
Key clinical point: Nivolumab demonstrated encouraging clinical efficacy and tolerability in patients with platinum-resistant ovarian cancer.
Majo...
News Author: Roxanne Nelson Publish date: September 3, 2015
Key clinical point: Obinutuzumab was associated with a higher overall response rate as compared with rituximab, but obinutuzumab’s clinical benefit...
News Author: Roxanne Nelson Publish date: September 2, 2015
Key clinical point: CAR-modified T cell therapy lacks the toxicities and limitations of allogeneic stem cell transplantation and may be an effecti...
News Author: Roxanne Nelson Publish date: August 31, 2015
Key clinical point: Men with favorable-risk prostate cancer have a low risk of progression to a lethal phenotype and should consider active survei...
News Author: Roxanne Nelson Publish date: August 25, 2015
Key clinical point: Leukemia-associated mutations that persisted 30 days after chemotherapy initiation were associated with a significantly increa...
News Author: Roxanne Nelson Publish date: August 24, 2015
Key clinical point: Lenalidomide combined with rituximab is more active in recurrent follicular lymphoma, compared with lenalidomide monotherapy. M...
News Author: Roxanne Nelson Publish date: August 17, 2015
Key clinical point: A group-based behavioral weight loss intervention can lead to clinically meaningful weight loss in overweight/obese breast can...
News Author: Roxanne Nelson Publish date: August 17, 2015
Key clinical point: Continuous therapy improved outcomes in multiple myeloma, compared with fixed duration therapy.
Major finding: Overall surviva...
News Author: Roxanne Nelson Publish date: August 11, 2015
A novel combination of dexamethasone, cyclosporine, and rituximab was well tolerated in patients with chronic ITP, and significantly increased relapse...
